Andrew McLachlan

We estimate Andrew McLachlan received a parliamentary salary of: $239,270

Based on the Remuneration Tribunal base salary of $239,270 plus any additional allowance for ministerial, shadow or office-holder roles held at time of generation.

• Latest quarter total: $112,222
• Office Consumables and Services: $1,839
• Printing and Communications: $3,379
• Travel Allowance: $9,370
• Telecommunications - Usage: $1,146
• Private-Plated Vehicle: $4,109
• COMCAR: $2,462
• Fares: $13,608
• Domestic Travel: $14,724
• Parliamentary Delegations: $15,669
• Office Facilities - Not stated: $45,917

• Liberals can rule again if they take a simple lesson from their defeat – but Taylor’s Trumpian plan strays from the light | Tom McIlroy
• Pauline Hanson’s One Nation likely to win second South Australian lower house seat
• ‘Denial machine’: climate misinformation is fuelling conflict in Australian communities, inquiry finds
• Petrol prices are rising, but Australians don’t appear to be driving less or taking public transport more – yet
• PM tables election review in question time – as it happened
• Hanson calls censure motion a ‘stunt’ before leaving chamber – as it happened
• Moderate Liberals warn Angus Taylor against adopting Trump-style immigration policies
• New leader targets immigration in first comments after spill – as it happened
• Labor strikes deal with Greens on nature laws overhaul amid criticism ‘dirty deal’ being ‘rammed through’
• David Pocock says PM ‘seems to be holding up’ gambling ad reform – as it happened

• Politics with Michelle Grattan: Liberal Andrew McLachlan on why he’ll still promote net zero (2025-11-18)
  Michelle Grattan
  The South Australian Liberal senator says he’s ‘dubious’ about being able to sell the Coalition’s new policy to voters – describing it as ‘carefree with emissions’.
• Could taking hydroxychloroquine for coronavirus be more harmful than helpful? (2020-06-05)
  Andrew McLachlan, Ric Day
  People taking hydroxychloroquine for coronavirus may be more likely to die, according to new research. But that doesn’t mean the drug is killing them.
• Lidia Thorpe alleges she was ‘sexually assaulted’ by Liberal senator David Van – a claim he brands ‘disgusting’ (2023-06-14)
  Michelle Grattan
  Thorpe made the claim while Van was attacking Labor for politicising the Brittany Higgins allegation that she was raped in the office of then minister Linda Reynolds in 2019
• The evidence is in. WHO says corticosteroids really do save lives of people critically ill with COVID-19 (2020-09-04)
  Andrew McLachlan
  Common and cheap drugs save lives of patients critically ill with COVID-19, a new analysis shows. But these corticosteroids are not a cure.
• What is pentosan polysulphate sodium (PPS) and why are AFL players using it? (2018-04-06)
  Nial Wheate, Andrew McLachlan
  While PPS is approved in oral capsule form to treat bladder inflammation, it is not yet approved as in injection for knee and bone problems. But AFL players have been given special access.
• Medicines to treat side effects of other medicines? Sometimes less is more beneficial (2016-08-09)
  Jesse Jansen, Andrew McLachlan, Carissa Bonner, Vasi Naganathan
  Taking multiple medicines strongly increases the risk of unwanted side effects such as drowsiness, dizziness, confusion, falls and injuries and even hospitalisations.
• Thinking of trying ivermectin for COVID? Here’s what can happen with this controversial drug (2021-09-02)
  Nial Wheate, Andrew McLachlan, Slade Matthews
  Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
• Head lice drug Ivermectin is being tested as a possible coronavirus treatment, but that’s no reason to buy it (2020-04-06)
  Andrew McLachlan
  The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don’t know if it will work as a treatment for people with coronavirus.
• A major ivermectin study has been withdrawn, so what now for the controversial drug? (2021-07-22)
  Andrew McLachlan
  Investigations have led to the withdrawal of a study backing ivermectin to treat COVID-19. But that’s not the last time we’ll hear about this controversial drug.
• Opioids don’t relieve acute low back or neck pain – and can result in worse pain, new study finds (2023-06-28)
  Christine Lin, Andrew McLachlan, Caitlin Jones, Christopher Maher
  Opioids are the one of the most prescribed pain-relief for people with low back and neck pain. But new research shows they don’t effectively relieve low back or neck pain and can result in worse pain.
• University of Sydney
  University of Sydney
  Professor Andrew McLachlan is Head of School and Dean of Pharmacy at the University of Sydney. He is a pharmacist, academic and researcher experienced in clinical and experimental pharmacology and research…
• Making more drugs available ‘over the counter’ would be a win for the public and the health care system (2019-03-27)
  Jack Collins, Andrew McLachlan, Carl Schneider, Rebekah Moles, Stephen Carter
  A greater number of medicines may soon be available without a prescription. Under the right circumstances, this would mean you could bypass the doctor and access the treatments you need more quickly.
• Curing with blood: the rise and fall of COVID convalescent plasma therapy (2021-10-07)
  Andrew McLachlan, Sophie Stocker
  Plasma therapy sounded great at the start of the pandemic. Give COVID patients blood plasma from people who had recovered. But the evidence is in. It doesn’t work.
• Despite escalating prescriptions, nerve pain drug offers no relief for sciatica (2017-03-23)
  Christine Lin, Andrew McLachlan
  Prescriptions of the drug pregabalin to treat sciatica have skyrocketed in recent years. But a new study shows it brings only side effects, and not relief for sufferers.
• Ivermectin is still not a miracle cure for COVID-19, despite what you may have read (2020-08-18)
  Andrew McLachlan
  The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
• Instant prescriptions might be the way of our digital future, but we need to manage the risks first (2020-02-11)
  Jonathan Penm, Andrew McLachlan, Carl Schneider, Tim Usherwood
  The convenience of digital consultations can be compelling. But these services aren’t without risk – especially when people don’t interact directly with a health-care professional.
• Weekly Dose: paracetamol may be our favourite mild painkiller, but it doesn’t work for everything (2016-05-04)
  Andrew McLachlan
  Paracetamol is one of the most widely used medicines in Australia and around the world with millions of doses administered worldwide each day.
• Weekly Dose: Digoxin, the heart medicine that may have given us Van Gogh’s Starry Night (2016-05-25)
  Andrew McLachlan
  Many suspect Van Gogh suffered from foxglove extract overdose due to the yellow halos in his paintings and his portrait of his physician holding the plant.
• Health check: why do we get motion sickness and what’s the best way to treat it? (2019-05-07)
  Ric Day, Andrew McLachlan
  Motion sickness can make you feel pretty wretched. But there are a few things you can do to try and prevent it, or to treat it once it takes hold.
• I can’t sleep. What drugs can I (safely) take? (2018-09-18)
  Ric Day, Andrew McLachlan
  With so many different types out there, it’s hard to know what sleep medications are safe to use. Here’s a guide.
• Angus Taylor defeats Sussan Ley by hefty margin of 34-17 as Liberal leader (2026-02-12)
  Michelle Grattan
  Angus Taylor has defeated Sussan Ley for Liberal leader by a hefty margin of 34-17, giving him strong authority.
• University of Sydney
  University of Sydney
  Professor Andrew McLachlan is Head of School and Dean of Pharmacy at the University of Sydney. He is a pharmacist, academic and researcher experienced in clinical and experimental pharmacology and research…
• Liberals’ former immigration spokesman Paul Scarr crosses floor to support Hanson Muslim censure (2026-03-02)
  Michelle Grattan
  The Senate chose to censor Senator Pauline Hanson over her comments on Muslims.
• View from The Hill: Conservative Liberals hold ‘power walk’ before delivering coup de grâce to net zero (2025-11-12)
  Michelle Grattan
  The Liberals are set to dump net zero with a strong majority of the party room speaking out against the policy.
• Why shield laws can be ineffective in protecting journalists’ sources (2018-08-13)
  Rick Sarre
  Shield laws are meant to help investigative journalists do their work, but significant loopholes remain.
• Grattan on Friday: Aggrieved Liberals stamp their feet, testing Sussan Ley’s authority (2025-07-31)
  Michelle Grattan
  As any leader of a political party knows, when you demote people they can become difficult, or worse, for Sussan Ley her problems seem vast.
• Premier League’s front-of-shirt gambling ad ban is a flawed approach. Australia should learn from it (2023-04-28)
  Samantha Thomas, Hannah Pitt, Simone McCarthy
  It’s important Australia doesn’t follow the ineffective voluntary approach to gambling marketing that the UK is taking.
• Booing Adam Goodes – racism is in the stitching of the AFL (2015-07-29)
  Keith Parry
  Sydney Swans player Adam Goodes was yet again booed by Australian football fans at the weekend. Sadly, AFL supporters have a history of emphasising notions of “difference” by abusing Indigenous players.
• Demetriou’s resignation leaves big boots to fill for the AFL (2014-03-04)
  Matt Harvey
  Andrew Demetriou yesterday announced his retirement at the end of the 2014 season after 11 years at the helm of the AFL. The announcement was made at a set-piece press conference presided over by AFL Commission…
• The antithesis of healing: the AFL turns away from truth-telling again, ending Hawthorn investigation (2023-06-01)
  Matthew Klugman, Tracey Cooper
  After eight months of an inquiry there are ‘no adverse findings’ against former Hawthorn staff.
• The AFL needs real cultural change. Can the new chief deliver it? (2023-05-03)
  Michelle O'Shea, Alison Pullen
  Diversity is vital for developing the AFL, but the league needs to consider the structural and cultural barriers to attracting this diverse talent in the first place.
• AFL must change ticketing and ‘Ugby’ rules that drive away fans (2014-04-30)
  Stephen Alomes
  Is Australian football, the “people’s game” in its traditional motto, under threat? Will it remain Australia’s number one sport in its bicentenary year 2058? Or will the AFL’s greedy ticket pricing and…
• University of Sydney
  University of Sydney
  Professor Andrew McLachlan is Head of School and Dean of Pharmacy at the University of Sydney. He is a pharmacist, academic and researcher experienced in clinical and experimental pharmacology and research…